Riskpilot← Back to searchSign inGet full accessAlvind Läkarkonsult AB
ABActiveOrg 5591338347Storgatan 21General medical practice activities · NACE 8621Est. 20171 employees
Revenue 2024
SEK 0
EBITDA margin
—
-194% vs 2023
Equity ratio
54.2%
Financial strength
Net profit 2024
SEK -3K
-112% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -4K | -194% |
| Net profit | SEK -3K | -112% |
| Total assets | SEK 69K | -4% |
| Equity | SEK 37K | -7% |
| Employees | 1 | — |
Legal name
Alvind Läkarkonsult AB
Org number
5591338347
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
15 november 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Al-Windi, Ahmad
Company purpose
Läkarverksamhet allmänmedicin och geriatrik Konsult Rådgivning Föreläsning
Address
Storgatan 21
Email
ahmad.alwindi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 43 | 179 | 0 | 0 | 0 |
| Staff expenses | — | — | −8 | −0 | — |
| EBITDA | — | 125 | −8 | −1 | −4 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 0 | 125 | −8 | −1 | −4 |
| Net financials | — | — | — | — | 1 |
| Profit before tax | −120 | 93 | −8 | −1 | −3 |
| Tax | −0 | −19 | — | — | — |
| Net profit | −120 | 74 | −8 | −1 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 50 | 175 | 73 | 71 | 69 |
| Equity | 50 | 124 | 42 | 40 | 37 |
| Long-term debt | 0 | 0 | — | — | 9 |
| Short-term debt | 0 | 19 | 0 | — | — |
| Total debt | — | 19 | — | — | 9 |
EBITDA margin
-419100.0%
This company
15.8%
Market median
-2652632% vs market
20202024
Equity ratio
54.2%
This company
38.2%
Market median
+42% vs market
20202024
Return on equity
-8.1%
This company
18.4%
Market median
-144% vs market
20202024
Net profit margin
-301900.0%
This company
8.1%
Market median
-3727260% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alvind Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ahmad Al-Windi | Chief Executive Officer | 0 companies |
| Joni Joel Michael Al-Windi | Deputy Board Member | 0 companies |
| Paywand Candish Jonas Al-Windi | Board of Directors | 0 companies |